RA Capital Management, L.P., Director, 10% Owner at Artiva Biotherapeutics, Inc. (ARTV), bought 160,354 shares at $8.93 ($1.4M) on 2026-07-16, disclosed to the SEC on 2026-07-20.
Open-market purchase of $1.4M ARTV by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.93 | 152,472 | $1.4M | 95.1% |
| 2 | $8.95 | 7,882 | $71K | 4.9% |
| Total | $8.93 avg | 160,354 | $1.4M | 100% |
| Filing → |
| ARTV | BUY | 2026-07-31 | $456K | — | Filing → |
| ARTV | BUY | 2026-07-28 | $413K | — | Filing → |
| ARTV | BUY | 2026-07-23 | $2.6M | — | Filing → |